Resumen
In silico screening of a collection of 1584 academic compounds identified a small molecule hit for the human adenosine A2A receptor (pK i = 6.2) containing a novel chromene scaffold (3a). To explore the structure-activity relationships of this new chemical series for adenosine receptors, a focused library of 43 2H-chromene-3-carboxamide derivatives was synthesized and tested in radioligand binding assays at human adenosine A 1, A2A, A2B and A3 receptors. The series was found to be enriched with bioactive compounds for adenosine receptors, with 14 molecules showing submicromolar affinity (pKi ≥ 6.0) for at least one adenosine receptor subtype. These results provide evidence that the chromene scaffold, a core structure present in natural products from a wide variety of plants, vegetables, and fruits, constitutes a valuable source for novel therapeutic agents.
| Idioma original | Inglés |
|---|---|
| Páginas (desde-hasta) | 303-310 |
| Número de páginas | 8 |
| Publicación | European Journal of Medicinal Chemistry |
| Volumen | 54 |
| DOI | |
| Estado | Publicada - ago 2012 |
| Publicado de forma externa | Sí |
Huella
Profundice en los temas de investigación de 'New chromene scaffolds for adenosine A2A receptors: Synthesis, pharmacology and structure-activity relationships'. En conjunto forman una huella única.Citar esto
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver